Education
About Us
Working with TipRanks
Follow Us
MediXall Group Inc (MDXL)
OTHER OTC:MDXL
Total Valuation
MediXall Group has a market cap or net worth of $20.55K. The enterprise value is $3.84M.
Market Cap$20.55K
Enterprise Value$3.84M
Share Statistics
MediXall Group has 205,506,010 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding205,506,010
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MediXall Group’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 145.40%.
Return on Equity (ROE)0.70
Return on Assets (ROA)-22.69
Return on Invested Capital (ROIC)145.40%
Return on Capital Employed (ROCE)0.60
Revenue Per Employee44.20K
Profits Per Employee-651.92K
Employee Count7
Asset Turnover1.54
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MediXall Group is ―. MediXall Group’s PEG ratio is 0.00029.
PE Ratio―
PS Ratio0.16
PB Ratio>-0.01
Price to Fair Value>-0.01
Price to FCF-0.04
Price to Operating Cash Flow-0.01
PEG Ratio0.00029
Income Statement
In the last 12 months, MediXall Group had revenue of 309.42K and earned -4.56M in profits. Earnings per share was -0.04.
Revenue309.42K
Gross Profit72.91K
Operating Income-3.92M
Pretax Income-4.56M
Net Income-4.56M
EBITDA-3.88M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -1.20M and capital expenditures 0.00, giving a free cash flow of -1.20M billion.
Operating Cash Flow-1.20M
Free Cash Flow-1.20M
Free Cash Flow per Share>-0.01
Dividends & Yields
MediXall Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta127.05
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)―
Important Dates
MediXall Group upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
MediXall Group as a current ratio of <0.01, with Debt / Equity ratio of -58.71%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap75.30
Net Debt to EBITDA-0.98
Interest Coverage Ratio-6.05
Taxes
In the past 12 months, MediXall Group has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MediXall Group EV to EBITDA ratio is -1.00, with an EV/FCF ratio of -3.15.
EV to Sales12.51
EV to EBITDA-1.00
EV to Free Cash Flow-3.15
EV to Operating Cash Flow-3.15
Balance Sheet
MediXall Group has $31.92K in cash and marketable securities with $430.43K in debt, giving a net cash position of -$398.51K billion.
Cash & Marketable Securities$31.92K
Total Debt$430.43K
Net Cash-$398.51K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.05
Margins
Gross margin is 23.56%, with operating margin of -1265.64%, and net profit margin of -1474.82%.
Gross Margin23.56%
Operating Margin-1265.64%
Pretax Margin-1474.82%
Net Profit Margin-1474.82%
EBITDA Margin-1254.56%
EBIT Margin-1265.64%
Analyst Forecast
The average price target for MediXall Group is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―